Cerus Corp.
(NASDAQ : CERS)

( )
CERS After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
DHRDanaher Corp. -0.99%312.940.7%$867.68m
TMOThermo Fisher Scientific, Inc. 1.36%636.111.0%$866.41m
ABTAbbott Laboratories 1.48%130.280.8%$678.64m
MDTMedtronic Plc -0.36%106.890.6%$653.82m
ISRGIntuitive Surgical, Inc. -1.74%321.630.8%$451.32m
BDXBecton, Dickinson & Co. 0.92%244.161.0%$391.58m
BSXBoston Scientific Corp. -0.35%39.461.0%$356.67m
DXCMDexCom, Inc. -7.27%519.497.8%$351.01m
SYKStryker Corp. -0.23%246.841.3%$337.44m
ALGNAlign Technology, Inc. -0.83%619.756.4%$305.16m
EWEdwards Lifesciences Corp. -1.20%108.500.4%$259.28m
AAgilent Technologies, Inc. -1.14%149.271.6%$244.82m
ZBHZimmer Biomet Holdings, Inc. -1.42%121.181.7%$232.60m
IDXXIDEXX Laboratories, Inc. -2.08%586.543.8%$216.99m
WSTWest Pharmaceutical Services, Inc. -0.75%434.111.6%$184.00m

Company Profile

Cerus Corp. engages in the research, development, and manufacture of biomedical and surgical products. The firm produces blood system for platelets and plasma. It operates through Blood Safety segment. It markets products under the INTERCEPT brand. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA.